• Request sample

Apheresis Equipment Market Synopsis:

Apheresis Equipment Market Size Was Valued at USD 2.9 Billion in 2023, and is Projected to Reach USD 6.40 Billion by 2032, Growing at a CAGR of 9.20% From 2024-2032.

The Apheresis Equipment Market describes the branch of industries that supply or synthesize the equipment typically used in apheresis – the process of the blood component extraction to obtain required plasma, platelets, or leukocytes. It also has a significant use in blood donation being used by health facilities to get and use specific blood derivative for different intended purposes in therapy.

The key reasons that have allowed the growth of the Apheresis Equipment Market include the rising incidence of chronic diseases, including cancer, autoimmune diseases, and certain blood disorders that need frequent rounds of apheresis. With modern healthcare concentrating on dollar specific treatment plans and patient-centered care, there will be an increased use apheresis technologies demanding more enhanced apheresis equipment.

Nowadays the blood donation and plasma collection awareness and activities are growing notably, particularly in developed countries. Blood donation centre and the governments along with the healthcare industry are playing a key role in promoting blood donation camps thereby helping them to identify the need for effective and efficient apheresis equipment.

Apheresis Equipment Market - Comprehensive Study Report & Recent Trends 2024-2032

Apheresis Equipment Market Trend Analysis:

Technological advancement in apheresis machines

  • A key factor initiating the increased demand for Apheresis Equipment Market is the upgraded technology in apheresis machines allowing the use of automation and artificial intelligence. Such improvements increase the performance of blood component separators and benefit patients in ways that boost health care organisations’ effectiveness. In addition, there is a growing availability of more transportable and easy-to-use apheresis devices where clinics procedures can be accomplished, and more commonly in outpatient clinics.
  • One new trend of the company is that single-use disposable apheresis kits are also used more and more since they is safer and more convenient to use. These kits help reduce contamination chances and simplify apheresis work, making them ideal especially for health care providers who wish to advance their modalities as they keep the patient’s health in check.

Healthcare infrastructure is rapidly developing.

  • The Apheresis Equipment Market has great potential for growth especially in the aforementioned emerging markets given the relatively new focus on development of healthcare in many countries. So when these regions improve their health standards, there is an increased need for such sophisticated devices as apheresis. The markets which such companies select should offer good growth prospects especially regarding the need for blood component collection as well as for therapeutic apheresis procedures.
  • Moreover, growing tendencies towards regenerative medicine and application of apheresis in cellular therapies also open new opportunities for the market participants. In this regard, apheresis technology will also have a very critical role to play to complement advanced treatment modalities such as stem cell therapy as research continues What is more, the growth prospects are bright for apheresis technology driven companies as the requirement of cellular materials for apheresis proliferates.

Apheresis Equipment Market Segment Analysis:

Apheresis Equipment Market is Segmented on the basis of Product Type, Procedure Type, Application, End User, and Region

By Product Type, Apheresis Machines segment is expected to dominate the market during the forecast period

  • The apheresis equipment market is primarily segmented into two product types: Apheresis machines and disposables apheresis kits. Apheresis machines are advanced medical technology equipment with a distinct functionality to isolate blood parts respectively enable medical practitioners to harvest specific components like plasma, platelets or white blood cells for treatment, or for donor purposes. These machines apply several technological aspects in separating and processing patents hence resulting to better results from the various patients. On the other hand, disposable apheresis kits are purposely made collection and processing apparatus comprising all requisite parts required to accomplish the apheresis process within a single use; this reduces the chances of contamination hence increasing safety of both client and professionals. The pressures of infection control and safety of patient are the major factors that are influencing the market for these disposable kits since it helps to standardize the entire process. All together these product types are essential for apheresis treatment’s efficiency and safety.

By Application, Therapeutic Apheresis segment expected to held the largest share

  • Based on the application, the apheresis equipment market is divided into therapeutic apheresis equipment and donor apheresis equipment. Therapeutic aphaeresis is a medical procedure in which required blood elements of the affected patient are taken out in order to cure a number of diseases like autoimmune, renal diseases and some forms of cancer. This application is to relieve symptoms, decrease disease activity, and enhance patient’s quality, health, and longevity by selectively filtering out toxic material or abnormal cells from the circulatory system. On the other hand, donor apheresis entails the collection of blood components from donor and stored as blood transfusion products or used as therapeutic products. This method enables the harvesting of specific components, for example platelet or plasma components that are often critical in transfusion medicine and in managing patients with underlying diseases. Consequently, there has been the enhancing need for both therapeutic and donor apheresis due to a rising incidence in chronic diseases and attention paid to blood donation camps.

Apheresis Equipment Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • North America holds the largest share for apheresis equipment due to the improved health care facility and technological innovation in this region. Other factors contributing to this region dominance includes the presence of key market players, high levels of research activities, and a good reimbursement policy. High incidence of chronic disease and increasing healthcare cost also propels the apheresis equipment growth in North America market.
  • In addition, the increasing emphasis on value added care, new methods, and treatment techniques puts this region on a footing for furthering apheresis market growth. The involvement of care givers and technology implementers in improving apheresis procedures demonstrate the efforts in making patient care better, thus securing North America’s position as an important player in the market for apheresis equipment on a global level.

Active Key Players in the Apheresis Equipment Market:

  • Fresenius Kabi (Germany)
  • Terumo BCT (United States)
  • Haemonetics Corporation (United States)
  • Astellas Pharma Inc. (Japan)
  • Blood Centers of America (United States)
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • Medtronic plc (Ireland)
  • Koch Industries (United States)
  • Gambro (Sweden)
  • Dardilly (France)
  • Other Active Players

Apheresis Equipment Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 2.90 Billion

Forecast Period 2024-32 CAGR:

 9.20%

Market Size in 2032:

USD 6.40 Billion

Segments Covered:

By Product Type

  • Apheresis Machines
  • Disposable Apheresis Kits

By Procedure Type

  • Plasma Apheresis
  • Platelet Apheresis
  • Leukapheresis
  • Erythrocytapheresis
  • Other Apheresis Procedures

By Application

  • Therapeutic Apheresis
  • Donor Apheresis

By End User

  • Hospitals
  • Blood Donation Centers
  • Research Institutes
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing Prevalence of Chronic Diseases

Key Market Restraints:

  • Regulatory Challenges and Compliance Issues

Key Opportunities:

  • Expansion in Regenerative Medicine Applications

Companies Covered in the report:

  • Fresenius Kabi (Germany), Terumo BCT (United States), Haemonetics Corporation (United States), Astellas Pharma Inc. (Japan), Blood Centers of America (United States), Asahi Kasei Medical Co., Ltd. (Japan), Medtronic plc (Ireland), Koch Industries (United States), Gambro (Sweden), Dardilly (France). and Other Active Players.
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Apheresis Equipment Market research report?

The forecast period in the Apheresis Equipment Market research report is 2024-2032.

Who are the key players in the Apheresis Equipment Market?
What are the segments of the Apheresis Equipment Market?
What is the Apheresis Equipment Market?
How big is the Apheresis Equipment Market?